ENLIVEN THERAPEUTICS INC

Ticker: ELVN CUSIP: 29337E102 Class: Common Stock

Patient Square Capital LP's Holding History (CIK: 0001819257)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 308,141 Value ($000) $4,745 Avg Close $19.92 Range $15.14 - $24.64

Q3 2025

Shares 250,838 Value ($000) $5,135 Avg Close $20.16 Range $17.43 - $24.38

Q2 2025

Shares 245,838 Value ($000) $4,932 Avg Close $18.93 Range $13.30 - $24.11

Q1 2025

Shares 253,838 Value ($000) $4,996 Avg Close $21.52 Range $18.67 - $25.37

Q4 2024

Shares 224,038 Value ($000) $5,041 Avg Close $25.92 Range $21.43 - $30.03

Q3 2024

Shares 90,572 Value ($000) $2,313 Avg Close $23.16 Range $20.63 - $27.67

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	308,141	$4,745	$19.92	$15.14 - $24.64
Q3 2025	250,838	$5,135	$20.16	$17.43 - $24.38
Q2 2025	245,838	$4,932	$18.93	$13.30 - $24.11
Q1 2025	253,838	$4,996	$21.52	$18.67 - $25.37
Q4 2024	224,038	$5,041	$25.92	$21.43 - $30.03
Q3 2024	90,572	$2,313	$23.16	$20.63 - $27.67